This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 2 CIPO patents. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Edward N Van Den Brink - Innovator in Antibody Development.
Introduction: Edward N Van Den Brink is an inventor based in Halfweg, Netherlands. He is known for his work in the field of antibodies, particularly those binding to B7H4. His innovative approach aims to enhance therapeutic and diagnostic procedures, especially in cancer therapy.
Latest Patent Applications: Edward N Van Den Brink has developed a patent application related to antibodies binding to B7H4, including bispecific antibodies that also bind to CD3. The invention provides pharmaceutical compositions comprising these antibodies and outlines their use in therapeutic and diagnostic applications.
Conclusion: Edward N Van Den Brink's contributions to antibody development highlight the potential for advancements in cancer therapy through innovative applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile